Join the CIBRN Leaders for a webinar on Wednesday, May 22, 9:00 pm ET.

Please join the CIBRN Leaders for Webinar 1 of 2019 on Wednesday, May 22 at 9:00 pm ET. The webinar will review the recent discussions and podcast in the CIBRN community:

  • CIBRN 2019 Q1: Should drug approvals be based on efficacy and demonstrated need, or should pharmacoeconomics be a larger consideration? [View 5 replies to date]
  • CIBRN 2019 Q2: Should manufacturers’ rebates be kept confidential, or should full transparency be expected, in order to more properly compare costs between originators and biosimilars? [View 4 replies to date]
  • CIBRN Podcast Episode 1: Dr. Philip Baer on “Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States.” Current Medical Research Opinion, April 2019, Teeple et al. (3:18) [Listen to the podcast]

To connect to the webinar:

Step 1: Join the teleconference at 1-866-830-9434 and enter PIN 7994216

Step 2: Join the web portion by clicking on this link:
https://studio7communications.adobeconnect.com/cibrn_may22_2019/